Antibiotics 2013, 2(2), 206-216; doi:10.3390/antibiotics2020206
Review

Rifampicin Resistance: Fitness Costs and the Significance of Compensatory Evolution

Department of Medical Biochemistry and Microbiology / Box 582, Biomedical Center, Uppsala University, Husargatan 3, Uppsala 75423, Sweden
* Author to whom correspondence should be addressed.
Received: 1 February 2013; in revised form: 28 March 2013 / Accepted: 28 March 2013 / Published: 3 April 2013
(This article belongs to the Special Issue Antibiotic Resistance)
PDF Full-text Download PDF Full-Text [184 KB, uploaded 3 April 2013 16:21 CEST]
Abstract: Seventy years after the introduction of antibiotic chemotherapy to treat tuberculosis, problems caused by drug-resistance in Mycobacterium tuberculosis have become greater than ever. The discovery and development of novel drugs and drug combination therapies will be critical to managing these problematic infections. However, to maintain effective therapy in the long-term and to avoid repeating the mistakes of the past, it is essential that we understand how resistance to antibiotics evolves in M. tuberculosis. Recent studies in genomics and genetics, employing both clinical isolates and model organisms, have revealed that resistance to the frontline anti-tuberculosis drug, rifampicin, is very strongly associated with the selection of fitness compensatory mutations in the different subunits of RNA polymerase. This mode of resistance evolution may also apply to other drugs, and knowledge of the rates and mechanisms could be used to design improved diagnostics and by tracking the evolution of infectious strains, to inform the optimization of therapies.
Keywords: tuberculosis; Salmonella; genomics; genetics; combination therapy

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Hughes, D.; Brandis, G. Rifampicin Resistance: Fitness Costs and the Significance of Compensatory Evolution. Antibiotics 2013, 2, 206-216.

AMA Style

Hughes D, Brandis G. Rifampicin Resistance: Fitness Costs and the Significance of Compensatory Evolution. Antibiotics. 2013; 2(2):206-216.

Chicago/Turabian Style

Hughes, Diarmaid; Brandis, Gerrit. 2013. "Rifampicin Resistance: Fitness Costs and the Significance of Compensatory Evolution." Antibiotics 2, no. 2: 206-216.

Antibiotics EISSN 2079-6382 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert